EUVIMEDEUVIMED entdecken
Crossref

Genome-wide methylation analysis of treatment resistant schizophrenia

Vincenzo De Luca, Zanib Chaudhary, Nzaar Al-Chalabi, Jessica Qian, Carol Borlido, Philip Gerretsen, Ariel Graff, Gary Remington, Araba Chintoh

Journal of Neural Transmission · 2023

DOI: 10.1007/s00702-022-02585-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neural Transmission, 2023. Verfasst von Vincenzo De Luca und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, CAMH, University of Toronto, 250 College St, Toronto, M5T1R8, Canada. Vincenzo.deluca@camh.ca. Hauptthemen laut MEDLINE: Schizophrenia, Antipsychotic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Various studies have investigated the relationship between genetic polymorphisms of antipsychotic drug-metabolizing agents and drug response. DNA methylation is a form of epigenetic modification that regulates gene expression. Few studies have analyzed the relationship between genome-wide methylation patterns and treatment resistance schizophrenia. The primary aim of this pilot study is to investigate the association between treatment resistance status and genome-wide DNA methylation in schizophrenia patients. Treatment resistance status was determined for 109 patients with schizophrenia. Treatment resistance was the primary outcome variable in a model, including methylation status of white blood cells using the Illumina 450 array. The genome-wide DNA methylation levels in 109 Schizophrenia subjects did not show that DNA methylation sties were associated with resistance status. From our study, it is evident the importance of continuing to investigate the relationship between DNA methylation and antipsychotic response to personalize treatment in schizophrenia. Future studies require larger prescription databases to build on the results presented in this pilot study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaAntipsychotic AgentsHumansSchizophrenia, Treatment-ResistantPilot ProjectsDNA MethylationEpigenesis, GeneticGenome-Wide Association Study

Stichwörter der Autor:innen

AntipsychoticsEpigeneticsTreatment resistant schizophrenia

Substanzen

Antipsychotic Agents

Autor:innen und Institutionen

  • Department of Psychiatry, CAMH, University of Toronto, 250 College St, Toronto, M5T1R8, Canada. Vincenzo.deluca@camh.ca.
  • Department of Psychiatry, CAMH, University of Toronto, 250 College St, Toronto, M5T1R8, Canada.

Zitieren

APA

De Luca, V., Chaudhary, Z., Al-Chalabi, N., Qian, J., Borlido, C., Gerretsen, P., Graff, A., Remington, G., & Chintoh, A. (2023). Genome-wide methylation analysis of treatment resistant schizophrenia. Journal of Neural Transmission. https://doi.org/10.1007/s00702-022-02585-3

Vancouver

De Luca V, Chaudhary Z, Al-Chalabi N, Qian J, Borlido C, Gerretsen P, et al. Genome-wide methylation analysis of treatment resistant schizophrenia. Journal of Neural Transmission. 2023. doi:10.1007/s00702-022-02585-3

BibTeX
@article{DeLuca2023,
  author = {De Luca, Vincenzo and Chaudhary, Zanib and Al-Chalabi, Nzaar and Qian, Jessica and Borlido, Carol and Gerretsen, Philip and Graff, Ariel and Remington, Gary and Chintoh, Araba},
  title = {Genome-wide methylation analysis of treatment resistant schizophrenia},
  journal = {Journal of Neural Transmission},
  year = {2023},
  doi = {10.1007/s00702-022-02585-3}
}
Kostenlos starten →